Cargando…
Improving Cancer Immunotherapy: Exploring and Targeting Metabolism in Hypoxia Microenvironment
Although immunotherapy has achieved good results in various cancer types, a large proportion of patients are limited from the benefits. Hypoxia and metabolic reprogramming are the common and critical factors that impact immunotherapy response. Here, we present current research on the metabolism repr...
Autores principales: | Wei, Jinfen, Hu, Meiling, Du, Hongli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8907427/ https://www.ncbi.nlm.nih.gov/pubmed/35281061 http://dx.doi.org/10.3389/fimmu.2022.845923 |
Ejemplares similares
-
Single-Cell Transcriptome Analysis Reveals RGS1 as a New Marker and Promoting Factor for T-Cell Exhaustion in Multiple Cancers
por: Bai, Yunmeng, et al.
Publicado: (2021) -
The Promise of Targeting Hypoxia to Improve Cancer Immunotherapy: Mirage or Reality?
por: Janji, Bassam, et al.
Publicado: (2022) -
Targeted drug delivery system for ovarian cancer microenvironment: Improving the effects of immunotherapy
por: Peng, Hongling, et al.
Publicado: (2022) -
Characterization of Glycolysis-Associated Molecules in the Tumor Microenvironment Revealed by Pan-Cancer Tissues and Lung Cancer Single Cell Data
por: Wei, Jinfen, et al.
Publicado: (2020) -
Exploring the Emerging Role of the Gut Microbiota and Tumor Microenvironment in Cancer Immunotherapy
por: Qiu, Qin, et al.
Publicado: (2021)